RARRES2 and coronary artery disorder: In patients with CAD, chemerin correlated positively with android and total fat mass, c-peptide, fasting insulin, acute phase markers (all fractions of leukocytes, NLR, and hsCRP), platelet count, and adverse lipid profile (Table 3).